Key Insights

Highlights

Treatment Research

1 treatments under study, led by G207

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03911388Phase 1Recruiting

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

Showing all 1 trials

Research Network

Common Treatments

  • G2071

Active Sponsors

  • Treovir, Inc1
  • Cannonball Kids' Cancer Foundation1
  • M.D. Anderson Cancer Center1

Top Investigators

Related Conditions

  • Glioblastoma Of Cerebellum1
  • Pediatric Brain Tumor1
  • Cerebellar Neoplasm Malignant Primary1
  • Neoplasm Metastases1
  • Neoplasms1

Activity Timeline